Islet product characteristics and factors related to successful human islet transplantation from the collaborative islet transplant registry (CITR) 1999-2010

American Journal of Transplantation

Volumn 14, Issue 11, 2014, Pages 2595-2606

  Balamurugan, A N ^a   Naziruddin, B ^b   Lockridge, A ^a   Tiwari, M ^a   Loganathan, G ^a   Takita, M ^b   Matsumoto, S ^c   Papas, K ^d   Trieger, M ^e   Rainis, H ^e   Kin, T ^f   Kay, T W ^g   Wease, S ^e   Messinger, S ^h   Ricordi, C ^h   Alejandro, R ^h   Markmann, J ⁱ   Kerr Conti, J ^j   Rickels, M R ^k   Liu, C ^l   Zhang, X ^m   Witkowski, P ⁿ   Posselt, A ^o   Maffi, P ^p   Secchi, A ^p   Berney, T ^q   O'Connell, P J ^r   Hering, B J ^a   Barton, F B ^e   more..

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Annette C and Harold C Simmons Transplant Institute   (United States)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^d UNIVERSITY OF ARIZONA   (United States)

^e EMMES CORPORATION   (United States)

^f UNIVERSITY OF ALBERTA   (Canada)

^g ST VINCENT S HOSPITAL   (Australia)

^h UNIVERSITY OF MIAMI   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j LILLE UNIVERSITY HOSPITAL   (France)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

^l UNIVERSITY OF PENNSYLVANIA   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

ⁿ UNIVERSITY OF CHICAGO   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^q GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^r UNIVERSITY OF SYDNEY   (Australia)

more..

Author keywords

Clinical research practice; diabetes: type 1; endocrinology diabetology; health services and outcomes research; islet isolation; islet transplantation; Organ Procurement and Transplantation Network (OPTN); pancreas simultaneous pancreas kidney transplantation; registry registry analysis

Indexed keywords

C PEPTIDE; COLLAGENASE; DORNASE ALFA; ENDOTOXIN; HEMOGLOBIN A1C; INSULIN; LIBERASE; STEROID; THERMOLYSIN;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BODY MASS; BODY WEIGHT; CELL ISOLATION; DONOR; FEMALE; GRAFT RECIPIENT; HEMATOCRIT; HUMAN; HUMAN CELL; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRESERVATION; REGISTER; RETROSPECTIVE STUDY; STEROID THERAPY; GRAFT SURVIVAL; MIDDLE AGED;

ADULT; FEMALE; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; REGISTRIES;

EID: 84911391841     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12872     Document Type: Article

References (58)

1. Brandhorst H, Brandhorst D, Hering BJ, Federlin K, Bretzel RG., Body mass index of pancreatic donors: A decisive factor for human islet isolation. Exp Clin Endocrinol Diabetes 1995; 103 (Suppl 2): 23-26.
2. Lakey JR, Warnock GL, Rajotte RV, et al. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 1996; 61: 1047-1053.
3. Goto M, Johansson U, Eich TM, et al. Key factors for human islet isolation and clinical transplantation. Transplant Proc 2005; 37: 1315-1316.
4. Nano R, Clissi B, Melzi R, et al. Islet isolation for allotransplantation: Variables associated with successful islet yield and graft function. Diabetologia 2005; 48: 906-912.
5. Kim SC, Han DJ, Kang CH, et al. Analysis on donor and isolation-related factors of successful isolation of human islet of Langerhans from human cadaveric donors. Transplant Proc 2005; 37: 3402-3403.
6. O'Gorman D, Kin T, Murdoch T, et al. The standardization of pancreatic donors for islet isolations. Transplantation 2005; 80: 801-806.
7. Ponte GM, Pileggi A, Messinger S, et al. Toward maximizing the success rates of human islet isolation: Influence of donor and isolation factors. Cell Transplant 2007; 16: 595-607.
8. Koh A, Kin T, Imes S, Shapiro AM, Senior P., Islets isolated from donors with elevated HbA1c can be successfully transplanted. Transplantation 2008; 86: 1622-1624.
9. Liu X, Matsumoto S, Okitsu T, et al. Analysis of donor- and isolation-related variables from non-heart-beating donors (NHBDs) using the Kyoto islet isolation method. Cell Transplant 2008; 17: 649-656.
10. Niclauss N, Bosco D, Morel P, et al. Influence of donor age on islet isolation and transplantation outcome. Transplantation 2011; 91: 360-366.
11. Wang Y, Daneilson KK, Ropski A, et al. Systematic analysis of donor and isolation factor's impact on human islet yield and size distribution. Cell Transplant 2013; 22: 2323-2333.
12. Hilling DE, Bouwman E, Terpstra OT, Marang-van de Mheen PJ., Effects of donor-, pancreas-, and isolation-related variables on human islet isolation outcome: A systematic review. Cell Transplant 2014; 23: 921-928.
13. Kaddis JS, Danobeitia JS, Niland JC, Stiller T, Fernandez LA., Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes. Am J Transplant 2010; 10: 646-656.
14. Barton FB, Rickels MR, Alejandro R, et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care 2012; 35: 1436-1445.
15. Center CC., Seventh annual report of the Collaborative Islet Transplant Registry. 2011. Available at: http://www.citregistry.org/. Accessed February 12, 2014.
16. Sabek OM, Cowan P, Fraga DW, Gaber AO., The effect of isolation methods and the use of different enzymes on islet yield and in vivo function. Cell Transplant 2008; 17: 785-792.
17. Socci C, Davalli AM, Vignali A, et al. A significant increase of islet yield by early injection of collagenase into the pancreatic duct of young donors. Transplantation 1993; 55: 661-663.
18. Ricordi C., Islet transplantation: A brave new world. Diabetes 2003; 52: 1595-1603.
19. Movassat J, Saulnier C, Portha B., Insulin administration enhances growth of the beta-cell mass in streptozotocin-treated newborn rats. Diabetes 1997; 46: 1445-1452.
20. Kitamura T, Nakae J, Kitamura Y, et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 2002; 110: 1839-1847.
21. Kuroda Y, Kawamura T, Suzuki Y, Fujiwara H, Yamamoto K, Saitoh Y., A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation 1988; 46: 457-460.
22. Tanioka Y, Sutherland DE, Kuroda Y, et al. Excellence of the two-layer method (University of Wisconsin solution/perfluorochemical) in pancreas preservation before islet isolation. Surgery 1997; 122: 435-441; discussion 441-432.
23. Matsumoto S, Rigley TH, Qualley SA, Kuroda Y, Reems JA, Stevens RB., Efficacy of the oxygen-charged static two-layer method for short-term pancreas preservation and islet isolation from nonhuman primate and human pancreata. Cell Transplant 2002; 11: 769-777.
24. Papas KK, Colton CK, Nelson RA, et al. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice. Am J Transplant 2007; 7: 707-713.
25. Noguchi H, Ueda M, Hayashi S, et al. Comparison of M-Kyoto solution and histidine-tryptophan-ketoglutarate solution with a trypsin inhibitor for pancreas preservation in islet transplantation. Transplantation 2007; 84: 655-658.
26. Matsumoto S, Noguchi H, Hatanaka N, et al. Estimation of donor usability for islet transplantation in the United States with the Kyoto islet isolation method. Cell Transplant 2009; 18: 549-556.
27. Kin T, Mirbolooki M, Salehi P, et al. Islet isolation and transplantation outcomes of pancreas preserved with University of Wisconsin solution versus two-layer method using preoxygenated perfluorocarbon. Transplantation 2006; 82: 1286-1290.
28. Caballero-Corbalán J, Eich T, Lundgren T, et al. No beneficial effect of two-layer storage compared with UW-storage on human islet isolation and transplantation. Transplantation 2007; 84: 864-869.
29. Qin H, Matsumoto S, Klintmalm GB, De Vol EB., A meta-analysis for comparison of the two-layer and university of Wisconsin pancreas preservation methods in islet transplantation. Cell Transplant 2011; 20: 1127-1137.
30. Kin T, Senior P, O'Gorman D, Richer B, Salam A, Shapiro AM., Risk factors for islet loss during culture prior to transplantation. Transpl Int 2008; 21: 1029-1035.
31. Salehi P, Hansen MA, Avila JG, et al. Human islet isolation outcomes from pancreata preserved with histidine-tryptophan ketoglutarate versus University of Wisconsin solution. Transplantation 2006; 82: 983-985.
32. Stewart ZA, Cameron AM, Singer AL, Dagher NN, Montgomery RA, Segev DL., Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. Am J Transplant 2009; 9: 217-221.
33. Gaber AO, Fraga DW, Callicutt CS, Gerling IC, Sabek OM, Kotb MY., Improved in vivo pancreatic islet function after prolonged in vitro islet culture. Transplantation 2001; 72: 1730-1736.
34. Noguchi H, Naziruddin B, Jackson A, et al. Fresh islets are more effective for islet transplantation than cultured islets. Cell Transplant 2012; 21: 517-523.
35. Kedinger M, Haffen K, Grenier J, Eloy R., In vitro culture reduces immunogenicity of pancreatic endocrine islets. Nature 1977; 270: 736-738.
36. Lacy PE, Davie JM, Finke EH., Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. Science 1979; 204: 312-313.
37. Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS., Immunobiology of tissue transplantation: A return to the passenger leukocyte concept. Annu Rev Immunol 1983; 1: 143-173.
38. Cosimi S, Marchetti P, Giannarelli R, et al. Preparation and long-term storage by culture or cryopreservation of purified bovine pancreatic islets. Transplant Proc 1995; 27: 3355.
39. Markmann JF, Tomaszewski J, Posselt AM, et al. The effect of islet cell culture in vitro at 24 degrees C on graft survival and MHC antigen expression. Transplantation 1990; 49: 272-277.
40. Brendel MD, Kong SS, Alejandro R, Mintz DH., Improved functional survival of human islets of Langerhans in three-dimensional matrix culture. Cell Transplant 1994; 3: 427-435.
41. Korbutt GS, Pipeleers DG., Cold-preservation of pancreatic beta cells. Cell Transplant 1994; 3: 291-297.
42. Fraker CA, Cechin S, Alvarez-Cubela S, et al. A physiological pattern of oxygenation using perfluorocarbon-based culture devices maximizes pancreatic islet viability and enhances beta-cell function. Cell Transplant 2013; 22: 1723-1733.
43. Bucher P, Mathe Z, Bosco D, et al. Serva collagenase N B1: A new enzyme preparation for human islet isolation. Transplant Proc 2004; 36: 1143-1144.
44. Brandhorst H, Friberg A, Nilsson B, et al. Large-scale comparison of Liberase HI and collagenase NB1 utilized for human islet isolation. Cell Transplant 2010; 19: 3-8.
45. Iglesias I, Valiente L, Shiang KD, Ichii H, Kandeel F, Al-Abdullah IH., The effects of digestion enzymes on islet viability and cellular composition. Cell Transplant 2012; 21: 649-655.
46. Balamurugan AN, He J, Guo F, et al. Harmful delayed effects of exogenous isolation enzymes on isolated human islets: Relevance to clinical transplantation. Am J Transplant 2005; 5: 2671-2681.
47. Balamurugan AN, Breite AG, Anazawa T, et al. Successful human islet isolation and transplantation indicating the importance of class 1 collagenase and collagen degradation activity assay. Transplantation 2010; 89: 954-961.
48. Balamurugan AN, Loganathan G, Bellin MD, et al. A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products. Transplantation 2012; 93: 693-702.
49. Robertson GS, Chadwick DR, Contractor H, James RF, London NJ., The optimization of large-scale density gradient isolation of human islets. Acta Diabetol 1993; 30: 93-98.
50. Wei GH, Sun WP, Zhang J, et al. Comparison of continuous and discontinuous density gradient centrifugation for purification of human pancreatic islets. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27: 1352-1354.
51. Webb MA, Dennison AR, James RF., The potential benefit of non-purified islets preparations for islet transplantation. Biotechnol Genet Eng Rev 2012; 28: 101-114.
52. Kaddis JS, Olack BJ, Sowinski J, Cravens J, Contreras JL, Niland JC., Human pancreatic islets and diabetes research. JAMA 2009; 301: 1580-1587.
53. Shimoda M, Itoh T, Sugimoto K, et al. Improvement of collagenase distribution with the ductal preservation for human islet isolation. Islets 2012; 4: 130-137.
54. Friberg AS, Korsgren O, Hellgren M., A vast amount of enzyme activity fails to be absorbed within the human pancreas: Implications for cost-effective islet isolation procedures. Transplantation 2013; 95: e36-e38.
55. O'Gorman D, Kin T, Pawlick R, Imes S, Senior PA, Shapiro AM., Clinical islet isolation outcomes with a highly purified neutral protease for pancreas dissociation. Islets 2013; 5: 111-115.
56. Stahle M, Honkanen-Scott M, Ingvast S, Korsgren O, Friberg AS., Human islet isolation processing times shortened by one hour: Minimized incubation time between tissue harvest and islet purification. Transplantation 2013; 96: e91-e93.
57. Niclauss N, Sgroi A, Morel P, et al. Computer-assisted digital image analysis to quantify the mass and purity of isolated human islets before transplantation. Transplantation 2008; 86: 1603-1609.
58. Itoh T, Takita M, SoRelle JA, et al. Correlation of released HMGB1 levels with the degree of islet damage in mice and humans and with the outcomes of islet transplantation in mice. Cell Transplant 2012; 21: 1371-1381.